Cargando…
A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease
INTRODUCTION: Psychosis (delusions and/or hallucinations) is a well-recognized complication of treatment of Parkinson’s disease (PD). Quetiapine is a currently favored treatment, but data on its efficacy are equivocal. This trial aimed to provide further evidence on the efficacy of quetiapine in PD...
Autores principales: | Shotbolt, Paul, Samuel, Michael, Fox, Chris, David, Anthony S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699657/ https://www.ncbi.nlm.nih.gov/pubmed/19557142 |
Ejemplares similares
-
Quetiapine Relieved Pisa Syndrome in Patient With Parkinson Disease
por: Zhao, Junwu, et al.
Publicado: (2020) -
Comparison of Quetiapine and Risperidone in Treatment of Acute Psychosis: A Double-Blind, Randomized-Controlled Study
por: Moosavi, S. Mohamad, et al.
Publicado: (2015) -
Quetiapine and Wolff-Parkinson-White Syndrome
por: Chen, Michael, et al.
Publicado: (2020) -
Effects of quetiapine and olanzapine in patients with psychosis and violent behavior: a pilot randomized, open-label, comparative study
por: Gobbi, Gabriella, et al.
Publicado: (2014) -
A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease
por: Nichols, Michelle J, et al.
Publicado: (2013)